Shaperon
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | Phase 2 Trial of HY209gel in Atopic Dermatitis Patients Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp | Phase 2 | 2024-03-01 |
| Unknown | Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients COVID-19 Pneumonia | Phase 2 / Phase 3 | 2022-04-12 |
| Completed | Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients COVID19 Pneumonia | Phase 2 | 2020-09-24 |
| Completed | A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) Atopic Dermatitis | Phase 2 | 2020-08-26 |
| Completed | A Study of HY209 in Healthy Male Volunteers for Sepsis Sepsis | Phase 1 | 2019-12-05 |
| Completed | A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis Atopic Dermatitis | Phase 1 | 2018-01-29 |